Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Buttyan

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Oncotarget|November 22, 2017
Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cellsRuiqi Chen, Yinan Li, Ralph Buttyan, et al.
Expert Opinion on Investigational Drugs|September 23, 2006
Clinical trials of natural products as chemopreventive agents for prostate cancerDebra L Bemis, Aaron E Katz, Ralph Buttyan
The Prostate|October 26, 2011
Paracrine Hedgehog increases the steroidogenic potential of prostate stromal cells in a Gli-dependent mannerElina Levina, Mengqian Chen, Richard Carkner, et al.
Cancer Investigation|May 25, 2002
Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomasGlenda Gobé, Mark Rubin, Gail Williams, et al.
The Prostate|August 19, 2014
Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptorsNa Li, Mengqian Chen, Sarah Truong, et al.
Cell Stress & Chaperones|January 24, 2020
Erythropoietin promotes functional recovery via anti-apoptotic mechanisms in mouse unilateral ureteral obstructionElliya Park, Michael Cox, Kymora Scotland, et al.
Journal of Cellular Biochemistry|June 3, 2006
Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancerStéphane Terry, Xuezhen Yang, Min-Wei Chen, et al.
Cell Cycle (Georgetown, Tex.)|January 23, 2009
Androgenic regulation of hedgehog signaling pathway components in prostate cancer cellsMengqian Chen, Matthew Tanner, Alice C Levine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivoDebra L Bemis, Jillian L Capodice, Manisha Desai, et al.
Current Urology Reports|June 27, 2002
Tumor hypoxia and the progression of prostate cancerAristotelis G Anastasiadis, Brian C Stisser, Mohamed A Ghafar, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Oncotarget|November 22, 2017
Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cellsRuiqi Chen, Yinan Li, Ralph Buttyan, et al.
Expert Opinion on Investigational Drugs|September 23, 2006
Clinical trials of natural products as chemopreventive agents for prostate cancerDebra L Bemis, Aaron E Katz, Ralph Buttyan
The Prostate|October 26, 2011
Paracrine Hedgehog increases the steroidogenic potential of prostate stromal cells in a Gli-dependent mannerElina Levina, Mengqian Chen, Richard Carkner, et al.
Cancer Investigation|May 25, 2002
Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomasGlenda Gobé, Mark Rubin, Gail Williams, et al.
The Prostate|August 19, 2014
Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptorsNa Li, Mengqian Chen, Sarah Truong, et al.
Cell Stress & Chaperones|January 24, 2020
Erythropoietin promotes functional recovery via anti-apoptotic mechanisms in mouse unilateral ureteral obstructionElliya Park, Michael Cox, Kymora Scotland, et al.
Journal of Cellular Biochemistry|June 3, 2006
Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancerStéphane Terry, Xuezhen Yang, Min-Wei Chen, et al.
Cell Cycle (Georgetown, Tex.)|January 23, 2009
Androgenic regulation of hedgehog signaling pathway components in prostate cancer cellsMengqian Chen, Matthew Tanner, Alice C Levine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivoDebra L Bemis, Jillian L Capodice, Manisha Desai, et al.
Current Urology Reports|June 27, 2002
Tumor hypoxia and the progression of prostate cancerAristotelis G Anastasiadis, Brian C Stisser, Mohamed A Ghafar, et al.
Pageof 7